[go: up one dir, main page]

SI1539114T1 - Filmska obloga za tablete in kaplete - Google Patents

Filmska obloga za tablete in kaplete

Info

Publication number
SI1539114T1
SI1539114T1 SI200331978T SI200331978T SI1539114T1 SI 1539114 T1 SI1539114 T1 SI 1539114T1 SI 200331978 T SI200331978 T SI 200331978T SI 200331978 T SI200331978 T SI 200331978T SI 1539114 T1 SI1539114 T1 SI 1539114T1
Authority
SI
Slovenia
Prior art keywords
caplets
tablets
film coating
dosage forms
coating compositions
Prior art date
Application number
SI200331978T
Other languages
English (en)
Inventor
Dominique Nicolas Cade
Ewart Thomas Cole
Frederic Jean Joseph Hoehn
Robert Anthony Scott
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SI1539114T1 publication Critical patent/SI1539114T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Wrappers (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
SI200331978T 2002-08-09 2003-07-30 Filmska obloga za tablete in kaplete SI1539114T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02292020A EP1396263A1 (en) 2002-08-09 2002-08-09 Film coating for tablets and caplets
EP03784379A EP1539114B1 (en) 2002-08-09 2003-07-30 Film coating for tablets and caplets
PCT/IB2003/003442 WO2004014344A1 (en) 2002-08-09 2003-07-30 Film coating for tablets and caplets

Publications (1)

Publication Number Publication Date
SI1539114T1 true SI1539114T1 (sl) 2011-05-31

Family

ID=31502831

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331978T SI1539114T1 (sl) 2002-08-09 2003-07-30 Filmska obloga za tablete in kaplete

Country Status (16)

Country Link
US (3) US7914820B2 (sl)
EP (2) EP1396263A1 (sl)
JP (2) JP4652052B2 (sl)
CN (1) CN100500137C (sl)
AT (1) ATE497760T1 (sl)
AU (1) AU2003249464C1 (sl)
BR (1) BR0313220A (sl)
CA (1) CA2494045C (sl)
DE (1) DE60335991D1 (sl)
EA (1) EA007619B1 (sl)
ES (1) ES2357949T3 (sl)
MX (1) MXPA05001605A (sl)
NZ (1) NZ537750A (sl)
PT (1) PT1539114E (sl)
SI (1) SI1539114T1 (sl)
WO (1) WO2004014344A1 (sl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
ES2416072T3 (es) 2006-09-15 2013-07-30 Capsugel Belgium Nv Forma de dosificación de disgregación rápida
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
KR20140076621A (ko) * 2011-10-12 2014-06-20 다우 글로벌 테크놀로지스 엘엘씨 사출 성형된 투여형
WO2015187736A1 (en) * 2014-06-02 2015-12-10 Allergen Research Corporation Placebo formulations and uses thereof
WO2016105498A1 (en) 2014-12-23 2016-06-30 Synthetic Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
AU2018313766A1 (en) 2017-08-07 2020-02-20 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
CA3087569A1 (en) 2018-01-09 2019-07-18 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
KR20200125637A (ko) 2018-02-23 2020-11-04 크레스토보 홀딩스 엘엘씨 마이크로바이옴 관련 면역요법
WO2019183208A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Intestinal alkaline phosphatase formulations
CA3094174A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
CN109535496A (zh) * 2018-11-13 2019-03-29 黄冈师范学院 一种可降解的透水性包衣膜的制备方法
US20220257726A1 (en) 2019-07-18 2022-08-18 Synthetic Biologics, Inc. Intestinal alkaline phosphatase-based treatments of metabolic disorders
WO2021016081A1 (en) 2019-07-19 2021-01-28 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
CA3154308A1 (en) 2019-09-13 2021-03-18 Mark Smith Compositions and methods for treating autism spectrum disorder
JP2022552005A (ja) 2019-10-18 2022-12-14 フィンチ セラピューティクス ホールディングス エルエルシー 細菌代謝産物を対象に送達するための組成物および方法
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
WO2021142353A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatitis b (hbv) and hepatitis d (hdv)
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
US20230201265A1 (en) 2020-03-31 2023-06-29 Finch Therapeutics Holdings Llc Compositions comprising non-viable fecal microbiota and methods of use thereof
US20240263251A1 (en) 2021-02-19 2024-08-08 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA753851B (en) * 1974-08-01 1976-05-26 Ici Ltd Film coating process
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
GB2256648B (en) * 1991-05-29 1995-08-30 Colorcon Ltd Wax polish composition
JPH05144624A (ja) 1991-11-21 1993-06-11 Mitsubishi Steel Mfg Co Ltd 磁気記録媒体およびその製造方法
KR940703886A (ko) * 1992-01-17 1994-12-12 토머스 디. 뵈닝 셀룰로오스 중합체 및 락토오스 기재 필름 코팅 조성물 및 필름 코팅(Film Coatings and Film Coating Compositions Based on Cellulosic Polymers and Lactose)
TW237386B (sl) * 1992-04-15 1995-01-01 Ciba Geigy
JPH06157325A (ja) * 1992-11-30 1994-06-03 Mitsubishi Kasei Corp 経口コレステロール低下剤
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
PT797424E (pt) * 1994-12-16 2000-10-31 Warner Lambert Co Processo para a encapsulacao de "caplets" numa capsula e formas de dosagem solida por tal processo
US6245350B1 (en) * 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
ES2226128T3 (es) * 1997-06-11 2005-03-16 THE PROCTER & GAMBLE COMPANY Comprimido revestido con una pelicula para una seguridad del tracto gastrointestinal superior mejorada.
JP3677156B2 (ja) * 1997-09-05 2005-07-27 武田薬品工業株式会社 医薬
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
DE10033023A1 (de) * 2000-07-07 2002-01-31 Biogrund Gmbh Filmüberzugszusammensetzung auf Basis von Zellulosederivaten und Zuckeralkoholen
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
JP3885484B2 (ja) * 2000-11-07 2007-02-21 カシオ計算機株式会社 データ通信処理装置及び記録媒体
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
JP5144624B2 (ja) 2009-10-28 2013-02-13 京セラドキュメントソリューションズ株式会社 画像形成装置

Also Published As

Publication number Publication date
NZ537750A (en) 2007-09-28
US7914820B2 (en) 2011-03-29
DE60335991D1 (de) 2011-03-24
CA2494045C (en) 2010-01-05
US20110142925A1 (en) 2011-06-16
WO2004014344A1 (en) 2004-02-19
JP2011026337A (ja) 2011-02-10
EA007619B1 (ru) 2006-12-29
BR0313220A (pt) 2005-06-14
AU2003249464C1 (en) 2009-03-05
EP1396263A1 (en) 2004-03-10
US20050249810A1 (en) 2005-11-10
CN1674876A (zh) 2005-09-28
CN100500137C (zh) 2009-06-17
JP4652052B2 (ja) 2011-03-16
EA200500074A1 (ru) 2005-08-25
ES2357949T3 (es) 2011-05-04
ATE497760T1 (de) 2011-02-15
US20140105975A1 (en) 2014-04-17
EP1539114B1 (en) 2011-02-09
PT1539114E (pt) 2011-03-24
MXPA05001605A (es) 2005-04-25
JP2005539019A (ja) 2005-12-22
CA2494045A1 (en) 2004-02-19
EP1539114A1 (en) 2005-06-15
AU2003249464A1 (en) 2004-02-25
AU2003249464B2 (en) 2008-09-25
US8557294B2 (en) 2013-10-15

Similar Documents

Publication Publication Date Title
SI1539114T1 (sl) Filmska obloga za tablete in kaplete
UA86413C2 (ru) Сахарное покрытие и твердая дозированая форма, которая его содержит
HUP0303886A3 (en) New film coating composition for coating of pharmaceutical compositions
BR0307833A (pt) Sìntese controlada de ziprasidona e suas composições
WO2003095455A3 (en) Substituted pyrazolopyrimidines
WO2004074244A3 (en) Pyrimidine compounds
TW200519075A (en) Novel compounds
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
MXPA05010682A (es) Compuestos novedosos.
WO2008070462A3 (en) N-oxides of 4,5-epoxy-morphinanium analogs
SE0101675D0 (sv) Novel composition
WO2004033418A3 (en) Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists
TW200738659A (en) Novel compounds
NO20062824L (no) 1,3-Difenylprop-2-en-1-on-avledete forbindelser, fremgangsmater for fremstilling derav, samt anvendelse av samme
TW200616960A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
TW200738283A (en) Formulations of conjugated estrogens and bazedoxifene
TW200630336A (en) Novel compounds
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO2006133006A3 (en) 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents
BRPI0512820A (pt) composição de matéria, e método de revestir um metal
WO2007027519A3 (en) Compositions and methods for darkening keratinous fibers
DE502006003012D1 (sl)
EE05182B1 (et) Asendatud homopiperidlbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon